Biomarker Discovery for Precision Medicine: an Artificial Intelligence based approach.
Bidragets beskrivning
Biomarker development is essential in modern health care, especially in individualization of treatments and precision medicine. Omics has attracted much attention to support discovery of novel biomarkers. However, of the estimated 1M biomarkers identified in omics studies only a small fraction (<1%) has achieved FDA approval. Failures in marker development equate to lost resources, time, and credibility for the field. I aim to use Artificial Intelligence methods to efficiently mine big biomedical data and quickly assess combinations of biomarkers from large-scale omics and clinical data. These AI-driven technologies will be used to discover highly predictive biomarkers of cardiovascular disease (CVD) and Alzheimer disease (AD). By speeding up the translation of omics-driven biomarker models for clinical utility, the proposed study will bring us closer to the future of non-invasive and highly accurate medical tests, which will be accessible and affordable to everyone.
Visa merStartår
2020
Slutår
2025
Beviljade finansiering
Andra beslut
358037
Akademiforskarens forskningskostnader(2023)
147 220 €
336275
Akademiforskarens forskningskostnader(2020)
219 658 €
Finansiär
Finlands Akademi
Typ av finansiering
Akademiforskare
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
332510
Vetenskapsområden
Biomedicinska vetenskaper
Forskningsområden
Systeemibiologia, bioinformatiikka
Identifierade teman
bioinformatics